96734 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof Linear peptides containing at least one abnormal peptide link
Methods of treating ophthalmic diseases using NPR-B agonists
#302Dimeric Smac Mimetics
#303IAP antagonists
#304Self-stabilizing linker conjugates
#305Auristatin compounds and conjugates thereof
#306N-carboxyalkyl-auristatin and the use thereof
#307Dendrimeric peptides, pharmaceutical compositions and methods of using the same
#308BRIDGED LIPOGLYCOPEPTIDES THAT POTENTIATE THE ACTIVITY OF BETA-LACTAM ANTIBACTERIALS
#309LINEAR ASSEMBLIES, BRANCHED ASSEMBLIES, MACROCYCLES AND COVALENT BUNDLES OF FUNCTIONALIZED BIS-PEPTIDES
#310ADIPOSE TISSUE TARGETED PEPTIDES
#311Dendrimeric peptides, pharmaceutical compositions and methods of using the same
#312Azapeptides as CD36 binding compounds
#313In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
#314Skin treatment devices and methods with pre-stressed configurations
#315Method of making biologically active alpha-beta peptides
#316Processes and intermediates
#317AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS
#318PEPTIDES INCORPORATING 3-AMINOADAMANTANE CARBOXYLIC ACIDS ENHANCE SYNAPTIC PLASTICITY AND ACT AS NEUROGENIC AGENTS
#319Use of novel amino acid derivatives as agents for treating human perspiration, and compositions containing them
#320Auristatin derivatives and use thereof
#321Cytotoxic peptides and antibody drug conjugates thereof
#322Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus
#323Growth hormone releasing peptides
#324Peptide derivatives, preparation and uses thereof
#325Binder-drug conjugates (ADCs) and use thereof
#326NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF
#327PROCESS FOR A FOLATE-TARGETED AGENT
#328Therapeutic peptides
#329Synthetic peptide amides for pain
#330INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE
#331Protein-polymer-drug conjugates
#332Peptidomimetic protease inhibitors
#333Methods and compositions for treating and diagnosing kidney disease
#334Methods and compositions for the treatment of metabolic disorders
#335Anti-HIV peptides and methods of use thereof
#336In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
#337RETRO-INVERSO PEPTIDES DERIVED FROM INTERLEUKIN-6
#338Self-assembling hydrogels based on dicephalic peptide amphiphiles
#339MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#340MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#341Contoxin analogues and methods for synthesis of intramolecular dicarba bridge-containing peptides
#342MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#343MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#344MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#345Beta-hairpin peptidomimetics having CXCR4 antagonizing activity
#346PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS
#347Solid phase peptide synthesis of peptide alcohols
#348Self-assembling peptides bearing organic electronic functionality and applications employing the same
#349Polyion complex comprising hydrophobized polyamino acid and use of the same
#350Neuromedin U derivative
#351Inhibitors of viral integrase and methods of use
#352Peptidomimetic protease inhibitors
#353Treatment devices and methods with extending elements
#354Skin treatment devices and methods with pre-stressed configurations
#355Methods of treating disorders by administration of F11 receptor antagonists
#356MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#357MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#358MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#359MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#360Functional lipid constructs
#361Branched amphipathic oligo-peptides that self-assemble into vesicles
#362Antibodies that bind alpha subunit of sodium potassium ATPase
#363Pepstatin A derivatives
#364SYNTHETIC PEPTIDE AND USES THEREOF
#365Monomethylvaline compounds capable of conjugation to ligands
#366Monomethylvaline compounds capable of conjugation to ligands
#367Inhibiting tumor cell invasion, metastasis and angiogenesis
#368Anticancer Compounds
#369Synthetic mimics of mammalian cell surface receptors: method and compositions
#370Dendrimeric peptides, pharmaceutical compositions and methods of using the same
#371INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II MOLECULES AND METHODS OF USE THEREOF
#372Uses of kappa opioid synthetic peptide amides
#373Dimeric Smac mimetics
#374Dipeptidyl peptidase IV (DP-IV) compounds
#375LIBRARIES OF PEPTIDE CONJUGATES AND METHODS FOR MAKING THEM
#376BIOMARKER DETECTION-2
#377Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use
#378Synthetic peptide amides and dimeric forms thereof
#379NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS
#380Cell penetrating peptides
#381Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#382Antineoplastic peptides
#383Peptide compounds exhibiting glucagon antagonist and GLP-1 agonist activity
#384ANTI-ANGIOGENIC COMPOUNDS
#385NPR-B agonists
#386Deuterated hepatitis C protease inhibitors
#387Metastin derivative and use thereof
#388Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#389Processes and intermediates for preparing steric compounds
#390Retro-inverso peptides derived from interleukin-6
#391METHODS AND SYSTEMS FOR TREATMENT AND/OR DIAGNOSIS
#392Antibacterial antisense oligonucleotide and method
#393Azapeptides as CD36 binding compounds
#394Method for preparing antibody monolayers which have controlled orientation using peptide hybrid
#395USE OF PEPTIDE DERIVATIVES FOR TREATING PATHOLOGIES RESULTING FROM ISCHEMIA
#396Thrombin substrate and assay for determining the level of bioactive thrombin in a sample
#397Processes and intermediates
#398SYNTHETIC MIMICS OF MAMMALIAN CELL SURFACE RECEPTORS: METHOD AND COMPOSITIONS
#399GUANIDINIUM DELIVERY CARRIERS
#400Peptidomimetic protease inhibitors
#401COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN
#402Targeted delivery to legumain-expressing cells
#403METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING KIDNEY DISEASE
#404Method of making biologically active alpha-beta peptides
#405POLY(AMINO ACID) COMPOUND HAVING INHIBITORY ACTIVITY ON ABSORPTION OF PHOSPHORUS AND PHOSPHORUS ABSORPTION INHIBITOR
#406Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same
#407Uses of synthetic peptide amides
#408Processes and intermediates
#409LIGANDS OF SH3 DOMAINS
#410Synthetic mimics of mammalian cell surface receptors: method and compositions
#411HCV protease inhibitors and uses thereof
#412Contoxin analogues and methods for synthesizing same
#413PEYER'S PATCH AND/OR M-CELL TARGETING LIGANDS
#414Substrate-mimetic Akt inhibitor
#415Peptide-based compounds
#416Methods for Determining the Cleavability of Substrates
#417Retro-Inversion Peptides That Target GIT Transport Receptors and Related Methods
#418ApoE mimetic agents
#419Methods and compositions related to cyclic peptide synthesis
#420SMALL PEPTIDIC AND PEPTIDO-MIMETIC AFFINITY LIGANDS FOR FACTOR VIII AND FACTOR VIII-LIKE PROTEINS
#421DICHROMIC FLUORESCENT COMPOUNDS
#422Synthetic mimics of mammalian cell surface receptors: method and compositions
#423Inhibiting tumor cell invasion, metastasis and angiogenesis
#424Methods for the treatment or prevention of scars and/or keloids
#425Synthetic peptide amides and dimeric forms thereof
#426Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
#427Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus
#428Modified Amino Acids
#429METASTIN DERIVATIVES AND USE THEREOF
#430Peptides for Use In Treating Obesity
#431Synthetic peptide amides
#432Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
#433Monomethylvaline compounds capable of conjugation to ligands
#434RADIOFLUORINATION
#435Radiolabelling via fluorination of aziridines
#436Monomethylvaline compounds having phenylalanine side-chain replacements at the C-terminus
#437Dendrimeric peptides, pharmaceutical compositions and methods of using the same
#438Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#439Isosteric Transormation
#440Antibacterial amide macrocycles VI
#441ANTIBACTERIAL AMIDE-MACROCYCLES V
#442Monomethylvaline compounds capable of conjugation to ligands
#443Monomethylvaline compounds capable of conjugation to ligands
#444Growth hormone releasing peptides
#445Compound Having Amino Acid Residue or Peptide Residue and Process for Producing the Same
#446Antineoplastic peptides
#447Microcin B17 Analogs And Methods For Their Preparation And Use
#448Monomethylvaline compounds capable of conjugation to ligands
#449COMPOUNDS AS APTAMER-DIMERS AND THEIR USES IN DIAGNOSIS AND THERAPY
#450Antibacterial antisense oligonucleotide and method
#451Peptide-based compounds
#452Anti-Angiogenic Compounds
#453Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same
#454Novel Proteasome Modulators
#455Myd88 Homodimerization Inhibitors
#456Methods to Treat Alzheimer's Disease
#457Protease susceptibility II
#458Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#459Multivalent chelators containing a scaffold structure for modifying and organizing of target molecules
#460Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
#461Protein kinase inhibitors and methods for identifying same
#462Processes and intermediates for preparing steric compounds
#463Peptides for use in treating obesity
#464Peptides as NS3-serine protease inhibitors of hepatitis C virus
#465Deuterated hepatitis C protease inhibitors
#466Light emitting probes
#467Conotoxin analogues and methods for synthesis of intramolecular dicarba bridge-containing peptides
#468[PSI[CH2NH]PG4] glycopeptide antibiotic analogs
#469Tamandarin analogs and fragments thereof and methods of making and using
#470Inactivators and bivalent inhibitors of glyoxalase I and methods of inhibiting tumor growth
#471Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them
#472Didemnin analogs and fragments and methods of making and using them
#473Processes and intermediates
#474Guanidinium delivery carriers
#475Multi-valent guanidinium compounds for enhancing molecular translocation across cellular membranes and epithelial tissues
#476Orally administered small peptides synergize statin activity
#477Method of using retro inverso peptides derived from leukemia inhibitory factor
#478Peptides as NS3-serine protease inhibitors of hepatitis C virus
#479Methods of using retro-inverso peptides derived from interleukin-6
#480Peptides and therapeutic uses thereof
#481Conjugates useful in the treatment of prostate cancer
#482Orthogonally protected bifunctional amino acid
#483Novel treatment
#484Hydrazide conjugates as imaging agents
#485Peptide derivatives having β-secretase inhibitory activity
#486Compounds to treat alzheimer's disease
#487Asymmetric dosing methods
#488Aza-peptides
#489Compounds to treat Alzheimer's disease
#490Modified antiviral peptides with increased activity and cell membrane affinity
#491Pentapeptide compounds and uses related thereto
#492Synthetic mimics of mammalian cell surface receptors: method and compositions
#493Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
#494Anti-angiogenic compounds
#495Gamma-carboxyglutamate containing conopeptides
#496Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same
#497Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use
#498Statine derivatives for the treatment of Alzheimer's disease II
#499Synthesis of epoxide based inhibitors of cysteine proteases
#500Conjugates useful in the treatment of prostate cancer
#501Lock for a flat and low pourer with a removable element in the form of a laminate of film for a composite package for container openings closed by nonpermeable film
#502Targeted delivery to legumain-expressing cells
#503Molecules which promote hematopoiesis
#504Antimicrobial peptides with reduced hemolysis and methods of their use
#505Method of modulating cellular activity and molecules for use therein
#506Synthesis and self-assembly of ABC triblock bola peptide amphiphiles
#507Substances K01-B0171 and process for producing the same
#508Low molecular weight peptidomimetic growth hormone secretagogues
#509Novel inhibitor of beta amyloid cleavage
#510Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient
#511Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNs) in a tissue, its selection, pharmaceutical compositions and use
#512Substituted ethane-1,2-diamines for the treatment of Alzheimer's disease
#513Alpha-4 beta-1 integrin ligands for imaging and therapy
#514Antineoplastic peptides
#515Immunosuppressant compounds, methods and uses related thereto
#516Formulation of boronic acid compounds
#517Novel treatment
#518Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease
#519Kinase mimic catalysts for asymmetric synthesis of phosphorylated inositols and cycloalkanols
#520Monomethylvaline compounds capable of conjugation to ligands
#521Process for the production of dendritic trimesic acid triamides
#522Peyer's patch and/or M-cell targeting ligands
#523Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#524Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
#525Multivalent compounds for crosslinking receptors and uses thereof
#526Peptidomimetic protease inhibitors
#527Synthesis of template-fixed β-hairpin loop mimetics
#528Peptides as NS3-serine protease inhibitors of hepatitis C virus
#529Conjugates of ligand linker and cytotoxic agent and related composition and methods of use
#530Orally administered small peptides synergize statin activity
#531Somatostatin agonists
#532Inhibitors of hepatitis C virus NS3/NS4a serine protease
#533Growth hormone releasing peptides
#534Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#535Chemotactic peptide antagonists for imaging sites of inflammation
#536Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
#537Peptide beta-strand mimics based on 1,2-dihydro-3(6H)-pyridinone
#538Octapeptide bombesin analogs
#539Stapled antimicrobial peptide
#540Controlled synthesis of hierarchically-structured hybrid materials through peptoid engineering
#541N-amino peptide beta-sheet mimics for the treatment of Alzheimer's disease
#542Cyclic peptide-based NPR-B agonists
#543RP-HPLC method for the analysis and quantification of pancreatin active pharmaceutical agents